D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA Cancer J Clin, vol.55, pp.74-108, 2002.

J. T. Schiller and D. R. Lowy, Virus infection and human cancer: an overview. Recent Results Cancer Res, vol.193, pp.1-10, 2014.

H. U. Bernard, R. D. Burk, Z. Chen, K. Van-doorslaer, H. Zur-hausen et al., Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments, Virology, vol.401, pp.70-79, 2010.

J. M. Walboomers, M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, pp.12-21, 1999.

E. M. Burd, Human papillomavirus and cervical cancer, Clin Microbiol Rev, vol.16, pp.1-17, 2003.

N. Muñoz, F. X. Bosch, S. De-sanjosé, R. Herrero, X. Castellsagué et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, vol.348, pp.518-545, 2003.

N. Muñoz, F. X. Bosch, X. Castellsagué, M. Díaz, S. De-sanjose et al., Against which human papillomavirus types shall we vaccinate and screen? The international perspective, Int J Cancer, vol.111, pp.278-85, 2004.

K. Münger, W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel, The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes, J Virol, vol.63, pp.4417-4438, 1989.

K. A. Gillespie, K. P. Mehta, L. A. Laimins, and C. A. Moody, Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers, J Virol, vol.86, pp.247-259, 2012.

S. Duensing and K. Münger, The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability, Cancer Res, vol.62, pp.7075-82, 2002.

M. Scheffner, J. M. Huibregtse, R. D. Vierstra, and P. M. Howley, The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p53, Cell, vol.75, pp.495-505, 1993.

P. Marchiole, A. Buenerd, M. Benchaib, K. Nezhat, D. Dargent et al., Clinical significance of lympho vascular space involvement and lymph node micrometastases in earlystage cervical cancer: a retrospective case-control surgicopathological study, Gynecol Oncol, vol.97, pp.727-759, 2005.

D. Cibula, N. R. Abu-rustum, L. Dusek, M. Zikan, A. Zaal et al., Prognostic significance of low volume sentinel lymph node disease in early-stage cervical www, oncotarget.com cancer. Gynecol Oncol, vol.124, pp.496-501, 2012.

E. Darai, R. Rouzier, M. Ballester, E. Barranger, and C. Coutant, Sentinel lymph node biopsy in gynaecological cancers: the importance of micrometastases in cervical cancer, Surg Oncol, vol.17, pp.227-262, 2008.

N. C. Gloyeske, W. Goreal, O. Neil, M. Connor, C. Tawfik et al., Outcomes of breast cancer patients with micrometastases and isolated tumor cells in sentinel lymph nodes, In Vivo, vol.25, pp.997-1001, 2011.

M. Balic, A. Williams, N. Dandachi, and R. J. Cote, Micrometastasis: detection methods and clinical importance, Cancer Biomark, vol.9, pp.397-419, 2011.

A. E. Giuliano, P. S. Dale, R. R. Turner, D. L. Morton, S. W. Evans et al., Improved axillary staging of breast cancer with sentinel lymphadenectomy, Ann Surg, vol.222, pp.399-401, 1995.

J. P. Diaz, M. L. Gemignani, N. Pandit-taskar, K. J. Park, M. P. Murray et al., Sentinel lymph node biopsy in the management of earlystage cervical carcinoma, Gynecol Oncol, vol.120, pp.347-52, 2011.

A. S. Bats, A. Buénerd, D. Querleu, E. Leblanc, E. Daraï et al., Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective

, Gynecol Oncol, vol.123, pp.230-235, 2011.

A. N. Fader, R. P. Edwards, M. Cost, A. Kanbour-shakir, J. L. Kelley et al., Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment, Gynecol Oncol, vol.111, pp.13-20, 2008.

A. Schoenfeld, Y. Luqmani, H. D. Sinnett, S. Shousha, and R. C. Coombes, Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients, Br J Cancer, vol.74, pp.1639-1681, 1996.

G. J. Liefers, A. M. Cleton-jansen, C. J. Van-de-velde, J. Hermans, J. H. Van-krieken et al., Micrometastases and survival in stage II colorectal cancer, N Engl J Med, vol.339, pp.223-231, 1998.

G. Cserni, Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification, J Clin Pathol, vol.65, pp.193-99, 2012.

P. O. Van-trappen, V. G. Gyselman, D. G. Lowe, A. Ryan, D. H. Oram et al., Molecular quantification and mapping of lymph-node micrometastases in cervical cancer, Lancet, vol.357, pp.15-20, 2001.

N. Hafner, M. Gajda, C. Altgassen, H. Hertel, C. Greinke et al., HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR, Int J Cancer, vol.120, pp.1842-1848, 2007.

V. Samouelian, F. Revillion, N. Alloy, V. Lhotellier, E. Leblanc et al., Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer, Int J Biol Markers, vol.23, pp.74-82, 2008.

M. Torabi, S. L. Aquino, and M. G. Harisinghani, Current concepts in lymph node imaging, J Nucl Med, vol.45, pp.1509-1527, 2004.

G. F. Schwartz, A. E. Giuliano, and U. Veronesi, Consensus Conference Committee. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, vol.33, pp.579-89, 2001.

P. Hermanek, Disseminated tumor cells versus micrometastasis: definitions and problems, Anticancer Res, vol.19, pp.2771-2775, 1999.

P. Hermanek, R. V. Hutter, L. H. Sobin, and C. Wittekind, International Union Against Cancer. Classification of isolated tumor cells and micrometastasis, Cancer, vol.86, pp.2668-73, 1999.

M. Srinivasan, D. Sedmak, and S. Jewell, Effect of fixatives and tissue processing on the content and integrity of nucleic acids, Am J Pathol, vol.161, pp.1961-71, 2002.

E. Skrzydlewska, M. Sulkowska, M. Koda, and S. Sulkowski, Proteolytic-antiproteolytic balance and its regulation in carcinogenesis, World J Gastroenterol, vol.11, pp.1251-66, 2005.

Y. Nagai, T. Maehama, T. Asato, and K. Kanazawa, Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan. Am J Clin Oncol, vol.24, pp.160-166, 2001.

C. M. Lee, D. C. Shrieve, K. A. Zempolich, R. J. Lee, E. Hammond et al., Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix

, Gynecol Oncol, vol.99, pp.415-436, 2005.

I. Fuchs, N. Vorsteher, H. Buhler, K. Evers, J. Sehouli et al., The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma, Anticancer Res, vol.27, pp.959-63, 2007.

S. M. Feng, C. I. Sartor, D. Hunter, H. Zhou, X. Yang et al., The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation, Mol Endocrinol, vol.21, pp.1861-76, 2007.

C. I. Sartor, H. Zhou, E. Kozlowska, K. Guttridge, E. Kawata et al., Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells, Mol Cell Biol, vol.21, pp.6412-6432, 2001.

C. M. Lee, R. J. Lee, E. Hammond, A. Tsodikov, M. Dodson et al., Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis

, Gynecol Oncol, vol.93, pp.209-223, 2004.

H. Kobayashi, S. Fujishiro, and T. Terao, Impact of urokinasetype plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus, Cancer Res, vol.54, pp.6539-6587, 1994.

P. O. Van-trappen, R. A. Carroll, M. Lecoeur, C. Goff, L. Gyselman et al., A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer, Br J Cancer, vol.87, pp.537-581, 2002.

S. Okamoto, H. Niikura, K. Nakabayashi, K. Hiyama, M. Matoda et al.,

N. Yaegashi, Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method

, Gynecol Oncol, vol.130, pp.530-536, 2013.

A. Jemal, E. P. Simard, C. Dorell, A. M. Noone, L. E. Markowitz et al., Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels, J Natl Cancer Inst, vol.105, pp.175-201, 2013.

D. Querleu, D. Dargent, Y. Ansquer, E. Leblanc, and F. Narducci, Extraperitoneal endosurgical aortic and common iliac dissection in the staging of bulky or advanced cervical carcinomas, Cancer, vol.88, pp.1883-91, 2000.

V. Pawlowski, F. Revillion, M. Hebbar, L. Hornez, and J. P. Peyrat, Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay, Clin Cancer Res, vol.6, pp.4217-4242, 2000.